Health
Nasal spray to fight COVID-19 could be manufactured in Australia – Manufacturers’ Monthly
A nasal treatment for COVID-19, common colds and flu is being taken to the next stage of testing, backed by the $500 million Biomedical Translation Fund.
A nasal treatment for COVID-19, common colds and flu is being taken to the next stage of testing, with backing from the federal government’s $500 million Biomedical Translation Fund.
Developed by Australian biotech company Ena Respiratory, INNA-051 works by stimulating the innate immune system, the first line of defence against the invasion of pathogens into the body.
The government, with Brandon Capital Partners has committed $11.7 million to test the nasal spray treatment, that targets the primary…
-
General18 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News18 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
Noosa News17 hours agoMurray Watt claims Queensland will follow Sussan Ley and ditch net zero by 2050
-
General15 hours agoRussian barrage kills 25 in Ukraine city as Zelenskyy holds talks with Turkish leader